Clinical Trial Update: Comparing Pump With Subcutaneous Injection Delivery of PTH 1-34 in the Management of Chronic Hypoparathyroidism [Phase 2]

View source ↗

Summary

Phase 2 trial update comparing pump-delivered PTH 1-34 with subcutaneous injections for chronic hypoparathyroidism; results from the study have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Polyglandular Syndrome Type
• Autosomal Dominant Hypocalcemia Type
• Hypocalcemia
• Hypoparathyroidism

Drugs mentioned

• Forteo (teriparatide)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Hypoparathyroidism, Hypocalcemia | Phase 2 | Status: COMPLETED | Results posted: 2026-03-04